BACKGROUND We developed an evidence service that draws inputs from Health Systems Evidence (HSE), which is a comprehensive database of research evidence about governance, financial and delivery arrangements within health systems and about implementation strategies relevant to health systems. Our goal was to evaluate whether, how and why a 'full-serve' evidence service increases the use of synth...

The work in part 6 of this series (J. Phys. Chem. A 2009, 113, 4930), addressing the task of separating the effects of Heisenberg spin exchange (HSE) and dipole-dipole interactions (DD) on electron paramagnetic resonance (EPR) spectra of nitroxide spin probes in solution, is extended experimentally and theoretically. Comprehensive measurements of perdeuterated 2,2,6,6-tetramethyl-4-oxopiperidin...

Gas refineries have been continuously focusing on Health, Safety and Environment programs to improve maintenance activities. Several researches have studied on this area with different analysis methods. This study presents an integrated approach for optimization of factors contributing to the implementation of Health, Safety and Environment (HSE) in maintenance activities. HSE managers in each ...

This report was produced for the HSE project on 'Assessment of Software Components for use in IEC 61508-Compliant Safety-Related Applications'. The main focus for this project is 'software of uncertain pedigree' (SOUP) used in safety-related applications. This document reviews current assessment methods for SOUP and summarises the evidence required for their use according to IEC 61508 and other...

Herpes simplex encephalitis (HSE) is a life-threatening complication of herpes simplex virus (HSV) infection. Acyclovir (ACV) is the antiviral treatment of choice, but may lead to emergence of ACV-resistant (ACVR) HSV due to mutations in the viral UL23 gene encoding for the ACV-targeted thymidine kinase (TK) protein. Here, we determined the prevalence of intrathecal ACVR-associated HSV TK mutat...

BACKGROUND Despite the proven efficacy of acyclovir (ACV) therapy, herpes simplex encephalitis (HSE) continues to cause substantial morbidity and mortality. Among patients with HSE treated with ACV, the mortality rate is approximately 14%-19%. Among survivors, 45%-60% have neuropsychological sequelae at 1 year. Thus, improving therapeutic approaches to HSE remains a high priority. METHODS Fol...